Wichterman Troy
- SEC CIK
- 0001892616
In the past year, 6 open-market sale filings worth $873.5K and no purchases.
Current role at each company
- BLFS Biolife Solutions IncChief Financial Officeras of Sep 22, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $873.5K
- 6 filings
- Net
- −$873.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Wichterman Troy as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 14, 2025 (view filing) | Oct 9 | 5 days | Wichterman TroyChief Financial Officer | SSale | −833 | $27.36 | −$22.8K | −0.5%183.4K after | 10b5-1 |
| Nov 28, 2025 (view filing) | Nov 25 | 3 days | Wichterman TroyChief Financial Officer | SSale | −584 | $26.74 | −$15.6K | −0.3%182.8K after | 10b5-1 |
| Dec 5, 2025 (view filing) | Dec 4 | 1 day | Wichterman TroyChief Financial Officer | SSale | −30.0K | $25.72 | −$771.6K | −16.4%152.8K after | |
| Dec 17, 2025 (view filing) | Dec 9 | 8 daysLate | Wichterman TroyChief Financial Officer | SSale | −1.03K | $25.13 | −$26.0K | −0.7%151.7K after | 10b5-1 |
| Jan 8, 2026 (view filing) | Jan 6 | 2 days | Wichterman TroyChief Financial Officer | SSale | −990 | $25.59 | −$25.3K | −0.7%150.7K after | 10b5-1 |
| Mar 5, 2026 (view filing) | Mar 3 | 2 days | Wichterman TroyChief Financial Officer | SSale | −588 | $20.74 | −$12.2K | −0.3%220.6K after | 10b5-1 |